← Evidence map

ArticleCombinatorial chemistry & high throughput screening2025

SLC16A3 is a Prognostic Marker and Affects Immune Regulation in Bladder Cancer.

Chengjun Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38956920